Brief: Hansa Biopharma Says PDUFA Action Date For Imlifidase BLA Set For December 19, 2026
04/03/2026 21:10
March 4 (Reuters) - Hansa Biopharma AB HNSA.ST: HANSA BIOPHARMA AB: PDUFA ACTION DATE FOR HANSA BIOPHARMA'S IMLIFIDASE BLA SET FOR DECEMBER 19, 2026 Source text: ID:nWkrQl00p Further company coverage: HNSA.ST ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS